A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States
Clinical trial NCT05374525 · COMPLETED
Trial details
- NCT number
- NCT05374525
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-08-08
- Enrollment
- 287
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.